etofylline clofibrate has been researched along with Hyperlipoproteinemia Type III in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Metz, G; Specker, M; Ziegler, WJ | 1 |
1 other study(ies) available for etofylline clofibrate and Hyperlipoproteinemia Type III
| Article | Year |
|---|---|
[Clinical effects and tolerance of etofylline clofibrate].
Topics: Clofibrate; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hypolipidemic Agents | 1980 |